Discontinuation report MINT-IRBESARTAN/HCTZ

Last updated on 2021-08-11 History
Report ID 143959
Drug Identification Number 02393026
Brand name MINT-IRBESARTAN/HCTZ
Common or Proper name Irbesartan HCTZ
Company Name MINT PHARMACEUTICALS INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) HYDROCHLOROTHIAZIDE IRBESARTAN
Strength(s) 25MG 300MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2020-07-08
Remaining supply date 2021-08-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6575 DAVAND DRIVE
MISSISSAUGA, ONTARIO
CANADA L5T 2M3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2021-08-11 French Compare
v1 2021-08-11 English Compare

Showing 1 to 2 of 2